Alternative names (7)
hasTherapeuticArea • mainTherapeuticAreas • majorTherapeuticAreas • majorTherapyAreas • therapeutic area • therapeuticAreas • therapeuticTargetRandom triples
| Subject | Object |
|---|---|
| gptkb:Verseau_Therapeutics | gptkb:immunotherapy |
| gptkb:NASDAQ:SAGE | psychiatry |
| gptkb:B01AF_(Enzymes) | cardiovascular system |
| gptkb:Phathom_Pharmaceuticals | acid-related disorders |
| gptkb:GSK_Pharma_India | gptkb:HIV |
| gptkb:Takeda_Pharmaceuticals | gastroenterology |
| gptkb:GW_Pharmaceuticals | oncology |
| gptkb:Odyssey_Therapeutics | gptkb:cancer |
| gptkb:Immunitas_Therapeutics | solid tumors |
| gptkb:Alkem_Laboratories | Cardiology |
| gptkb:DB12189 | gptkb:disease |
| gptkb:NASDAQ:SAGE | neurology |
| gptkb:Orbital_Therapeutics | oncology |
| gptkb:Ribon_Therapeutics | immunology |
| gptkb:Orna_Therapeutics | genetic diseases |
| gptkb:N03AF_group | antiepileptics |
| gptkb:Atara_Biotherapeutics | infectious diseases |
| gptkb:Passage_Bio | gptkb:GM1_gangliosidosis |
| gptkb:CHEMBL29997 | gptkb:attention_deficit_hyperactivity_disorder |
| gptkb:N02AA | pain management |